Deep Apple Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Deep Apple Therapeutics's estimated annual revenue is currently $5.3M per year.
- Deep Apple Therapeutics's estimated revenue per employee is $155,000
- Deep Apple Therapeutics's total funding is $57M.
Employee Data
- Deep Apple Therapeutics has 34 Employees.
- Deep Apple Therapeutics grew their employee count by 17% last year.
Deep Apple Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | VP and Head Drug Discovery | Reveal Email/Phone |
2 | VP, Head Biology and Translational Research | Reveal Email/Phone |
3 | VP, Head Biology and Translational Research | Reveal Email/Phone |
4 | VP and Head Drug Discovery | Reveal Email/Phone |
5 | Senior Director, Medicinal Chemistry and ADME Sciences | Reveal Email/Phone |
6 | Director biology | Reveal Email/Phone |
7 | Scientist | Reveal Email/Phone |
8 | Senior Principal Scientist, Head Structural Biology | Reveal Email/Phone |
9 | Senior Scientist - Structural Biology | Reveal Email/Phone |
10 | Principal Scientist | Reveal Email/Phone |
Deep Apple Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Deep Apple Therapeutics?
In a vast, unexplored virtual chemical space, Deep Apple Therapeutics moves with unprecedented speed to discover novel small molecules for high-value targets. Deep Apple combines ensemble cryo-EM to explore receptor conformations; deep learning; and the docking of multi-billion compound libraries generated using the company's proprietary Orchard.ai™ algorithm. Deep Apple's deep learning discovery engine is built upon founder expertise in computational modeling, protein and target structure determination, large-scale molecular docking, and the elucidation of protein dynamics and conformational transitions. This structure-based, machine-learning driven drug design approach enables the company to rapidly advance novel candidates addressing well-validated targets in inflammatory, metabolic, and endocrine diseases. For more information, visit deepappletx.com.
keywords:N/A$57M
Total Funding
34
Number of Employees
$5.3M
Revenue (est)
17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6M | 34 | -26% | N/A |
#2 | $7.5M | 34 | -3% | N/A |
#3 | $3.6M | 34 | -62% | $26M |
#4 | $3.9M | 34 | N/A | N/A |
#5 | $3.7M | 34 | 0% | $44M |